Journal article · 2017 · Open access

Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials

Virginia J. Howard, James Frederick Meschia, Brajesh K. Lal, Tanya N. Turan, Gary S. Roubin, Robert D. Brown, Jenifer H. Voeks, Kevin M. Barrett, Bart M. Demaerschalk, John Huston, Ronald M. Lazar, Wesley S. Moore and 6 more

International Journal of Stroke, 12(7), 770–778 · Published 2 May 2017 · DOI 10.1177/1747493017706238

Open full textView at the publisherCite this paper

In brief

“Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials” is a 2017 journal article by Virginia J. Howard and 17 co-authors, published in International Journal of Stroke. OpenAlex counts 232 citations as of 21 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
232
Most cited in
2020 (33)
Field-weighted impact
16.65
References
19
Authors
18

Abstract

Rationale Trials conducted decades ago demonstrated that carotid endarterectomy by skilled surgeons reduced stroke risk in asymptomatic patients. Developments in carotid stenting and improvements in medical prevention of stroke caused by atherothrombotic disease challenge understanding of the benefits of revascularization. Aim Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) will test whether carotid endarterectomy or carotid stenting plus contemporary intensive medical therapy is superior to intensive medical therapy alone in the primary prevention of stroke in patients with high-grade asymptomatic carotid stenosis. Methods and design CREST-2 is two multicenter randomized trials of revascularization plus intensive medical therapy versus intensive medical therapy alone. One trial randomizes patients to carotid endarterectomy plus intensive medical therapy versus intensive medical therapy alone; the other, to carotid stenting plus intensive medical therapy versus intensive medical therapy alone. The risk factor targets of centrally directed intensive medical therapy are LDL cholesterol <70 mg/dl and systolic blood pressure <140 mmHg. Study outcomes The primary outcome is the composite of stroke and death within 44 days following randomization and stroke ipsilateral to the target vessel thereafter, up to four years. Change in cognition and differences in major and minor stroke are secondary outcomes. Sample size Enrollment of 1240 patients in each trial provides 85% power to detect a treatment difference if the event rate in the intensive medical therapy alone arm is 4.8% higher or 2.8% lower than an anticipated 3.6% rate in the revascularization arm. Discussion Management of asymptomatic carotid stenosis requires contemporary randomized trials to address whether carotid endarterectomy or carotid stenting plus intensive medical therapy is superior in preventing stroke beyond intensive medical therapy alone. Whether carotid endarterectomy or carotid stenting has favorable effects on cognition will also be tested. Trial registration United States National Institutes of Health Clinicaltrials.gov NCT02089217.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Howard, V. J., Meschia, J. F., Lal, B. K., Turan, T. N., Roubin, G. S., Brown, R. D., Voeks, J. H., Barrett, K. M., Demaerschalk, B. M., Huston, J., Lazar, R. M., Moore, W. S., Wadley, V. G., Chaturvedi, S., Moy, C. S., Chimowitz, M. I., Howard, G., & Brott, T. G. (2017). Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. International Journal of Stroke, 12(7), 770–778. https://doi.org/10.1177/1747493017706238

MLA 9

Howard, Virginia J., et al. “Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials.” International Journal of Stroke, vol. 12, no. 7, 2017, pp. 770–778. https://doi.org/10.1177/1747493017706238.

Chicago

Howard, Virginia J., James Frederick Meschia, Brajesh K. Lal, Tanya N. Turan, Gary S. Roubin, Robert D. Brown, Jenifer H. Voeks, et al. 2017. “Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials.” International Journal of Stroke 12 (7): 770–778. https://doi.org/10.1177/1747493017706238.

Harvard

Howard, V. J. et al. (2017) ‘Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials’, International Journal of Stroke, 12(7), pp. 770–778. doi:10.1177/1747493017706238.

IEEE

V. J. Howard et al., “Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials,” International Journal of Stroke, vol. 12, no. 7, pp. 770–778, 2017, doi: 10.1177/1747493017706238.

BibTeX

@article{howard2017carotid,
  title     = {{Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials}},
  author    = {Howard, Virginia J. and Meschia, James Frederick and Lal, Brajesh K. and Turan, Tanya N. and Roubin, Gary S. and Brown, Robert D. and Voeks, Jenifer H. and Barrett, Kevin M. and Demaerschalk, Bart M. and Huston, John and Lazar, Ronald M. and Moore, Wesley S. and Wadley, Virginia G. and Chaturvedi, Seemant and Moy, Claudia Scala and Chimowitz, Marc I. and Howard, George and Brott, Thomas G.},
  journal   = {International Journal of Stroke},
  year      = {2017},
  volume    = {12},
  number    = {7},
  pages     = {770--778},
  doi       = {10.1177/1747493017706238},
  url       = {https://doi.org/10.1177/1747493017706238}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201799
20181818
20192727
20203333
20212929
20222929
20232525
20241616
20252323
20262222

Its field-weighted citation impact is 16.65: it has been cited 16.65 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases

  • asymptomatic carotid stenosis
  • carotid endarterectomy
  • carotid artery stenting
  • intensive medical therapy
  • stroke prevention
  • primary prevention
  • LDL cholesterol
  • systolic blood pressure

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Howard, V. J., Meschia, J. F., Lal, B. K., Turan, T. N., Roubin, G. S., Brown, R. D., Voeks, J. H., Barrett, K. M., Demaerschalk, B. M., Huston, J., Lazar, R. M., Moore, W. S., Wadley, V. G., Chaturvedi, S., Moy, C. S., Chimowitz, M. I., Howard, G., & Brott, T. G. (2017). Carotid revascularization and medical management for asymptomatic carotid stenosis: Protocol of the CREST-2 clinical trials. International Journal of Stroke, 12(7), 770–778. https://doi.org/10.1177/1747493017706238

How many times has this paper been cited?

232 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.

Who wrote this paper?

Virginia J. Howard, James Frederick Meschia, Brajesh K. Lal, Tanya N. Turan, Gary S. Roubin, Robert D. Brown, Jenifer H. Voeks, Kevin M. Barrett, Bart M. Demaerschalk, John Huston, Ronald M. Lazar, Wesley S. Moore and 6 more.

What is the DOI of this paper?

10.1177/1747493017706238, permanently at https://doi.org/10.1177/1747493017706238. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.